Share This Page
Drug Price Trends for ALL DAY ALLERGY-D TABLET
✉ Email this page to a colleague

Average Pharmacy Cost for ALL DAY ALLERGY-D TABLET
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
ALL DAY ALLERGY-D TABLET | 46122-0626-62 | 0.58521 | EACH | 2025-05-21 |
ALL DAY ALLERGY-D TABLET | 46122-0626-62 | 0.58148 | EACH | 2025-04-23 |
ALL DAY ALLERGY-D TABLET | 46122-0626-62 | 0.57862 | EACH | 2025-03-19 |
ALL DAY ALLERGY-D TABLET | 46122-0626-62 | 0.56835 | EACH | 2025-02-19 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for All Day Allergy-D Tablets
Introduction to All Day Allergy-D
All Day Allergy-D, commonly known for its active ingredients cetirizine and pseudoephedrine, is an antihistamine-decongestant combination used to treat allergic conditions such as allergic rhinitis. This medication is widely available in various forms, including oral tablets, and is a significant player in the allergy treatment market.
Global Allergy Treatment Market Overview
The global allergy treatment market is experiencing substantial growth, driven by several key factors. Here are some critical points to consider:
Market Size and Growth
The global allergy treatment market was estimated at USD 33.06 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.7% from 2024 to 2030[5].
Prevalence of Allergies
The high prevalence of allergies worldwide, estimated between 10% and 30% globally, significantly contributes to the market growth. This includes seasonal and perennial allergies, which are increasingly common in regions like North America and the Asia-Pacific[1].
Market Drivers
Therapeutics Segment
The therapeutics segment, which includes antihistamines like All Day Allergy-D, dominates the market with over 81.67% of the revenue share in 2023. These medications are effective in alleviating symptoms and providing relief from allergies, making them a staple in treatment plans[5].
Technological Advancements
Technological developments in treatment methods, such as new antihistamines and advancements in allergy diagnostics, are driving the market forward. Personalized allergy forecasts and symptom tracking tools are becoming more prevalent, enhancing patient care and treatment optimization[3][5].
Regulatory Landscape
A favorable regulatory landscape, particularly in regions like North America, supports the growth of the allergy treatment market. Strong regulatory frameworks ensure the safety and efficacy of medications like All Day Allergy-D, boosting consumer confidence[1].
Regional Market Dynamics
North America
North America dominated the market share in 2023, driven by a high disease burden and the strong presence of several manufacturers. The increasing prevalence of seasonal and perennial allergies in this region, along with consumer preference for non-drowsy formulations, is expected to propel market growth[1].
Asia-Pacific
The Asia-Pacific region is predicted to witness the fastest CAGR over the forecast period. Factors such as rapidly growing awareness of allergic ailments, a rising geriatric population prone to allergic conditions, and increasing lifestyle diseases are driving the growth in this region[1].
Price Analysis of All Day Allergy-D
Cost Structure
The cost of All Day Allergy-D tablets can vary based on the quantity and pharmacy.
-
Oral Tablet, Extended Release: The cost for All Day Allergy-D (5 mg-120 mg) oral tablet, extended release, is around $13.60 for a supply of 24 tablets. This translates to approximately $0.57 per unit[2].
-
Generic and Discount Options: Generic versions of cetirizine and pseudoephedrine combinations are available, which can significantly reduce the cost. For example, generic cetirizine/pseudoephedrine prices start from $11.55 for 12 tablets[2].
Price Breakdown
Quantity | Per Unit | Price |
---|---|---|
24 | $0.57 | $13.60 |
Patient Assistance and Copay Programs
While there are no specific patient assistance programs found for All Day Allergy-D, healthcare providers may have information on available programs in their area. Additionally, discount cards and copay programs can help reduce the cost of the medication[2].
Market Trends
Product Type Analysis
H-1 Blockers, which include drugs like cetirizine and loratadine, dominate the antihistamines market with over 58.3% share. These drugs are preferred for their efficacy in treating allergies with minimal sedative effects, making them suitable for daily use[4].
Dosage Forms Analysis
Tablets are the most popular dosage form, capturing more than 48.9% of the market share. Their user-friendly nature, exact dosing, and ease of use make them a top choice for consumers[4].
Key Factors Influencing Market Growth
- Increasing Prevalence of Allergies: The rising number of individuals suffering from allergies is a significant driver of market growth.
- Advancements in Diagnostics and Therapeutics: Technological advancements in treatment methods and diagnostics are enhancing patient care and treatment optimization.
- Consumer Preference: The preference for non-drowsy formulations and the ease of obtaining over-the-counter (OTC) antihistamines support market demand[1][3][5].
Illustrative Statistics
- The global loratadine market, which is part of the broader antihistamines market, was valued at USD 153.4 million in 2023 and is expected to grow at a CAGR of 2.9% from 2024 to 2030[1].
- The antihistamines market is expected to reach US$ 616 billion by 2033, growing at a CAGR of 8.1% from 2023[4].
Quotes from Industry Experts
"Technological developments in treatment methods and diagnostics are crucial for the growth of the allergy treatment market. Personalized allergy forecasts and symptom tracking tools are becoming more prevalent, enhancing patient care and treatment optimization." - [Industry Expert, The Business Research Company][3].
Conclusion
The market for All Day Allergy-D tablets is poised for significant growth, driven by the increasing prevalence of allergies, technological advancements, and favorable regulatory landscapes. The availability of generic versions and discount options can help make these medications more accessible to a wider audience.
Key Takeaways
- The global allergy treatment market is projected to grow significantly, driven by the increasing prevalence of allergies and advancements in diagnostics and therapeutics.
- The therapeutics segment, including medications like All Day Allergy-D, dominates the market due to its effectiveness in treating allergic conditions.
- Generic versions and discount options can significantly reduce the cost of All Day Allergy-D.
- Regional dynamics, particularly in North America and the Asia-Pacific region, play a crucial role in market growth.
FAQs
1. What is the current market size of the global allergy diagnostics and therapeutics market?
The global allergy diagnostics and therapeutics market size was estimated at USD 33.06 billion in 2023[5].
2. What is the projected growth rate of the allergy treatment market?
The market is projected to grow at a CAGR of 8.7% from 2024 to 2030[5].
3. What are the key factors driving the growth of the allergy treatment market?
Key factors include the rising prevalence of allergy disorders, increasing adoption of IVD techniques, and improving access to diagnostic tools in developing countries[5].
4. How much does All Day Allergy-D typically cost?
The cost for All Day Allergy-D (5 mg-120 mg) oral tablet, extended release, is around $13.60 for a supply of 24 tablets, translating to approximately $0.57 per unit[2].
5. Are there generic versions of All Day Allergy-D available?
Yes, generic versions of cetirizine and pseudoephedrine combinations are available, starting from $11.55 for 12 tablets[2].
Sources
- Grand View Research: Loratadine Market Size, Share, Growth, Trends Report, 2030.
- Drugs.com: All Day Allergy-D Prices, Coupons, Copay Cards & Patient Assistance.
- The Business Research Company: Global Allergic Rhinitis Drugs Market Report 2024.
- Market.us: Antihistamines Market Size, Share | CAGR Of 8.1%.
- DrugPatentWatch: Market Analysis and Price Projections for All Day Allergy.
More… ↓